Allurion gets ‘Notification of Issuance’ from USPTO for obesity treatment

Allurion Technologies (ALUR) announced that it has received an Issue Notification from the U.S. Patent and Trademark Office USPTO dated January 15 for U.S. Patent No. 12,209,677 titled “Binary Fluid Control Valve System”. This patent covers additional claims for an enhanced, next-generation version of Allurion’s proprietary Balloon technology and the introduction of innovative features, particularly to the precision of the valve system that controls balloon opening. The patent is expected to provide protection through July 2039. With the issuance of this patent, the Company now has 20 patents issued in the U.S. and 59 patents issued globally. Shantanu Gaur, Allurion’s Founder and CEO, noted, “Our new patent enhances our already robust, global patent portfolio. With it, we now have amassed 20 issued patents in the U.S. and 59 issued patents globally. This growing portfolio is a testament to the creativity of our R&D team, the moat we have built around our commercialization efforts, and the uniqueness of our innovative weight loss solutions for the treatment of obesity.”